#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunoglobulin G4 related disease Small intestine neuroendocrine tumour Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Epstein-Barr virus infection Precursor T-lymphoblastic lymphoma/leukaemia recurrent Short stature homeobox gene mutation Ataxia telangiectasia Chronic cutaneous lupus erythematosus Peritoneal neoplasm Desmoplastic small round cell tumour Skin angiosarcoma Malignant fibrous histiocytoma Laryngeal squamous cell carcinoma Trigeminal neuralgia Hypoxic-ischaemic encephalopathy More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Treatment Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Leiomyosarcoma metastatic – Trials in Disease Idiopathic pulmonary fibrosis – Trials in Disease Arterial tortuosity syndrome – Trials in Disease Uterine leiomyosarcoma – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Cystic fibrosis – Diagnostics Cholangitis sclerosing Mucopolysaccharidosis I – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dacarbazine Ergocalciferol Bp BIIB115 Tiapride Tofersen Cagrilintide Tebipenem Pivoxil Hydrobromide Fluorouracil Sodium Daxdilimab Darbepoetin Alfa Calcipotriol Elexacaftor Ovolecithin Alpha1H Pyridoxine Hydrochloride Bp Sodium Amylase Methadone Hydrochloride Absk021 Hydrochloride Hydrate Avutometinib More therapies…

    Learn about Your Condition

    Lung adenocarcinoma stage IV Encephalitis Japanese B Haemorrhage Cardiac arrest Vaginal infection Colorectal cancer stage II Thyroid mass Fracture infection Mastocytosis Magnetic resonance imaging Vasospasm Krabbe's disease Skin wrinkling Liver transplant rejection Mechanical ventilation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on Improving Knee Implant Stability in Osteoarthritis Patients Using Denosumab and Zoledronic Acid

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Sodium Chloride
    • Denosumab
    • Zoledronic Acid Monohydrate
    Denmark

  • Study on the Effects of Fordadistrogene Movaparvovec for Patients with Duchenne Muscular Dystrophy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Eculizumab
    Belgium France Germany Italy Spain

  • Study on the Long-Term Safety and Effectiveness of Filgotinib for Patients with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    Bulgaria Germany Hungary

  • Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Leflunomide
    • Hydroxychloroquine Sulfate
    • Azathioprine
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Other Analgesics And Antipyretics
    • Secukinumab
    Denmark Greece Hungary Italy Poland Spain

  • Study of Retatrutide (LY3437943) for Patients with Obesity or Overweight and Knee Osteoarthritis

    Not recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Ly3437943 Sodium
    Spain
Previous Page
1 … 58 59 60 61 62 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!